We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
6051
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$2K ﹤0.01%
71
-360
-84% -$24.9K
DMTK
6052
DELISTED
DermTech, Inc. Common Stock
DMTK
$2K ﹤0.01%
223
-18,574
-99% -$152K
BHIL.WS
6053
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
0
BSJN
6054
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$2K ﹤0.01%
96
-11,213
-99% -$267K
PCTI
6055
DELISTED
PCTEL, Inc. Common Stock
PCTI
$2K ﹤0.01%
435
-15
-3% -$63
INFI
6056
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2K ﹤0.01%
3,830
-47,795
-93% -$36.7K
SURF
6057
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2K ﹤0.01%
1,335
-20,747
-94% -$43.1K
MTEM
6058
DELISTED
Molecular Templates, Inc.
MTEM
$2K ﹤0.01%
151
-15,917
-99% -$372K
TWCBW
6059
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
0
HEXO
6060
DELISTED
HEXO Corp. Common Shares
HEXO
$2K ﹤0.01%
770
-1,039
-57% -$4.96K
RAAS
6061
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$2K ﹤0.01%
767
-548,766
-100% -$1.77M
SCPS
6062
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$2K ﹤0.01%
5,000
KIIIW
6063
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
0
HMTV
6064
DELISTED
Hemisphere Media Group, Inc.
HMTV
$2K ﹤0.01%
260
-177,861
-100% -$1.03M
NBEV
6065
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$2K ﹤0.01%
7,144
-65,476
-90% -$24.7K
AAOI icon
6066
Applied Optoelectronics
AAOI
$11.7B
$1K ﹤0.01%
336
ACIC icon
6067
American Coastal Insurance
ACIC
$465M
$1K ﹤0.01%
609
-9,534
-94% -$20.2K
ACTG icon
6068
Acacia Research
ACTG
$455M
$1K ﹤0.01%
118
-22,993
-99% -$105K
APLT
6069
DELISTED
Applied Therapeutics
APLT
$1K ﹤0.01%
1,222
-10,328
-89% -$16.9K
AQST icon
6070
Aquestive Therapeutics
AQST
$531M
$1K ﹤0.01%
1,731
-164,624
-99% -$219K
AVTX icon
6071
Avalo Therapeutics
AVTX
$1.05B
$1K ﹤0.01%
1
-9
-90% -$12K
BBU
6072
DELISTED
Brookfield Business Partners
BBU
$1K ﹤0.01%
73
BCX icon
6073
BlackRock Resources & Commodities Strategy Trust
BCX
$965M
$1K ﹤0.01%
+122
New +$1.29K
CLMT icon
6074
Calumet Specialty Products
CLMT
$4.15B
$1K ﹤0.01%
110
CNET icon
6075
ZW Data Action Technologies
CNET
$4.88M
$1K ﹤0.01%
210

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.